Pine Cone PPC Adjuvant Enhances T Cell Response

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for using pine cone extracts in vaccination and treatment lack understanding of their mechanism of action and require expensive equipment and complex procedures, while also being toxic to healthy cells.

Innovation Solution

Pine cone extracts, particularly the polyphenylpropanoid polysaccharide complex (PPC), are used as adjuvants to enhance immune responses by promoting the differentiation of dendritic and fibrocyte cells, offering a stable, inexpensive, and non-toxic solution for vaccination and treatment, easily administered without requiring expensive equipment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If pine cone extracts are used to enhance immune responses, then immune response enhancement is achieved, but toxicity to healthy cells occurs

Engineering Contradiction:
Improveimmune response enhancementVSAvoidtoxicity to healthy cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The pine cone extract is fractionated into multiple components (PPC, PPF, PSC, PSM) with distinct molecular weights and biological activities. This segmentation allows selection of specific fractions (particularly PPC with 10-100 kDa molecular weight) that provide immune enhancement while reducing toxicity to healthy cells.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different fractions of the pine cone extract exhibit different biological properties. The invention identifies that specific fractions (PPC: 10-100 kDa, PPF: 100-1000 kDa) have enhanced immune responses with reduced toxicity, allowing targeted use of these specific fractions rather than the crude extract.

Inventive Principle:
Principle #3Local quality

2Reliability

If complex procedures and expensive equipment are used for vaccination methods, then treatment efficacy is improved, but cost and complexity increase

Engineering Contradiction:
Improvetreatment efficacyVSAvoidprocedure complexity and equipment requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The pine cone extract fractions, particularly PPC, function as self-adjuvanting components that naturally enhance immune responses without requiring additional complex equipment or procedures. The extract itself provides the necessary immunomodulatory activity, eliminating the need for expensive specialized vaccination equipment.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The pine cone extract fractions serve multiple functions: they act as adjuvants to enhance immune responses, promote dendritic cell differentiation, and can be used with various types of vaccines (protein, nucleic acid, dendritic cell vaccines). This multi-functionality simplifies the overall vaccination approach without requiring different complex systems for different vaccine types.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If adjuvants are used to enhance immune responses, then immune response is boosted, but mechanism understanding is lacking

Engineering Contradiction:
Improveimmune response enhancementVSAvoidmechanism understanding
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

By fractionating the pine cone extract into distinct components (PPC, PPF, PSC, PSM) with characterized molecular weights and structures, the invention enables systematic study of each fraction's mechanism of action. This segmentation allows researchers to understand which specific components are responsible for immune enhancement and dendritic cell differentiation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention systematically varies parameters such as molecular weight cutoffs (10-100 kDa for PPC, 100-1000 kDa for PPF), pH levels (pH 2.0 for PSC, pH 12.0 for PSM), and extraction conditions to optimize immune response enhancement while elucidating the structure-activity relationships of different fractions.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9211326B2Method of enhancing the proliferative phase of a primary T cell response
Publication Date: 2015.12.15 TAMPA BAY RES INST
  • US9211326B2 patent drawing
  • US9211326B2 patent drawing
  • US9211326B2 patent drawing

AI summary

Disclosed is an alkaline extract of shredded pinecones yields a polyphenylpropanoid polysaccharide complex (PPC) that functions as an orally active immune adjuvant. Specifically, the oral PPC boosts the number of antigen-specific memory CD8+ T cells generated in response to a variety of vaccine types (DNA, protein, and dendritic cell) and bias the response towards one that is predominately a T helper 1 type. The oral PPC has potential for use be to enhance the T cell response generated by a variety of prophylactic and therapeutic vaccines designed to target a cellular response.